Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

pH-Responsive PLGA Nanoparticle for Controlled Payload Delivery of Diclofenac Sodium.

Khanal S, Adhikari U, Rijal NP, Bhattarai SR, Sankar J, Bhattarai N.

J Funct Biomater. 2016 Aug 2;7(3). pii: E21. doi: 10.3390/jfb7030021.

2.

A blue fluorescent labeling technique utilizing micro- and nanoparticles for tracking in LIVE/DEAD® stained pathogenic biofilms of Staphylococcus aureus and Burkholderia cepacia.

Klinger-Strobel M, Ernst J, Lautenschläger C, Pletz MW, Fischer D, Makarewicz O.

Int J Nanomedicine. 2016 Feb 5;11:575-83. doi: 10.2147/IJN.S98401. eCollection 2016.

3.

Cell penetrating peptide-modified poly(lactic-co-glycolic acid) nanoparticles with enhanced cell internalization.

Steinbach JM, Seo YE, Saltzman WM.

Acta Biomater. 2016 Jan;30:49-61. doi: 10.1016/j.actbio.2015.11.029. Epub 2015 Nov 18.

4.

Novel hydroxybutyl chitosan nanoparticles for siRNA delivery targeting tissue factor inhibits proliferation and induces apoptosis in human vascular smooth muscle cells.

Wan K, Li J, Li D, Ge J, Wang Y, Li X, Guo Y, Guo J, Leng M, Wang P, An Y.

Mol Med Rep. 2015 Dec;12(6):7957-62. doi: 10.3892/mmr.2015.4461. Epub 2015 Oct 21.

5.

Induction of mucosal immune responses and protection of cattle against direct-contact challenge by intranasal delivery with foot-and-mouth disease virus antigen mediated by nanoparticles.

Pan L, Zhang Z, Lv J, Zhou P, Hu W, Fang Y, Chen H, Liu X, Shao J, Zhao F, Ding Y, Lin T, Chang H, Zhang J, Zhang Y, Wang Y.

Int J Nanomedicine. 2014 Dec 2;9:5603-18. doi: 10.2147/IJN.S72318. eCollection 2014.

6.

Multifunctional nanoparticles for prostate cancer therapy.

Chandratre SS, Dash AK.

AAPS PharmSciTech. 2015 Feb;16(1):98-107. doi: 10.1208/s12249-014-0202-z. Epub 2014 Sep 5.

7.

Intranasal DNA Vaccine for Protection against Respiratory Infectious Diseases: The Delivery Perspectives.

Xu Y, Yuen PW, Lam JK.

Pharmaceutics. 2014 Jul 10;6(3):378-415. doi: 10.3390/pharmaceutics6030378.

8.

Physicochemical features and transfection properties of chitosan/poloxamer 188/poly(D,L-lactide-co-glycolide) nanoplexes.

Cosco D, Federico C, Maiuolo J, Bulotta S, Molinaro R, Paolino D, Tassone P, Fresta M.

Int J Nanomedicine. 2014 May 15;9:2359-72. doi: 10.2147/IJN.S58362. eCollection 2014.

9.

Drug-loaded nano-microcapsules delivery system mediated by ultrasound-targeted microbubble destruction: A promising therapy method.

Ma J, DU LF, Chen M, Wang HH, Xing LX, Jing LF, Li YH.

Biomed Rep. 2013 Jul;1(4):506-510. Epub 2013 May 21. Review.

10.

Overview of the role of nanotechnological innovations in the detection and treatment of solid tumors.

Frank D, Tyagi C, Tomar L, Choonara YE, du Toit LC, Kumar P, Penny C, Pillay V.

Int J Nanomedicine. 2014 Jan 22;9:589-613. doi: 10.2147/IJN.S50941. eCollection 2014. Review.

11.

Solid lipid nanoparticle-based calix[n]arenes and calix-resorcinarenes as building blocks: synthesis, formulation and characterization.

Montasser I, Shahgaldian P, Perret F, Coleman AW.

Int J Mol Sci. 2013 Nov 5;14(11):21899-942. doi: 10.3390/ijms141121899. Review.

12.

Preparation, characterization, and transport of dexamethasone-loaded polymeric nanoparticles across a human placental in vitro model.

Ali H, Kalashnikova I, White MA, Sherman M, Rytting E.

Int J Pharm. 2013 Sep 15;454(1):149-57. doi: 10.1016/j.ijpharm.2013.07.010. Epub 2013 Jul 12.

13.

Preparation, characterization, and in vitro and in vivo investigation of chitosan-coated poly (d,l-lactide-co-glycolide) nanoparticles for intestinal delivery of exendin-4.

Wang M, Zhang Y, Feng J, Gu T, Dong Q, Yang X, Sun Y, Wu Y, Chen Y, Kong W.

Int J Nanomedicine. 2013;8:1141-54. doi: 10.2147/IJN.S41457. Epub 2013 Mar 15.

14.

Surface modification of TPGS-b-(PCL-ran-PGA) nanoparticles with polyethyleneimine as a co-delivery system of TRAIL and endostatin for cervical cancer gene therapy.

Zheng Y, Chen H, Zeng X, Liu Z, Xiao X, Zhu Y, Gu D, Mei L.

Nanoscale Res Lett. 2013 Apr 9;8(1):161. doi: 10.1186/1556-276X-8-161.

15.

Concepts and practices used to develop functional PLGA-based nanoparticulate systems.

Sah H, Thoma LA, Desu HR, Sah E, Wood GC.

Int J Nanomedicine. 2013;8:747-65. doi: 10.2147/IJN.S40579. Epub 2013 Feb 21. Review.

16.

Microneedle-mediated transcutaneous immunization with plasmid DNA coated on cationic PLGA nanoparticles.

Kumar A, Wonganan P, Sandoval MA, Li X, Zhu S, Cui Z.

J Control Release. 2012 Oct 28;163(2):230-9. doi: 10.1016/j.jconrel.2012.08.011. Epub 2012 Aug 19.

17.

Biodegradable nanoparticles of mPEG-PLGA-PLL triblock copolymers as novel non-viral vectors for improving siRNA delivery and gene silencing.

Du J, Sun Y, Shi QS, Liu PF, Zhu MJ, Wang CH, Du LF, Duan YR.

Int J Mol Sci. 2012;13(1):516-33. doi: 10.3390/ijms13010516. Epub 2012 Jan 4.

18.

Effect of oleic acid modified polymeric bilayered nanoparticles on percutaneous delivery of spantide II and ketoprofen.

Shah PP, Desai PR, Singh M.

J Control Release. 2012 Mar 10;158(2):336-45. doi: 10.1016/j.jconrel.2011.11.016. Epub 2011 Nov 21.

19.

Intranasal delivery of cationic PLGA nano/microparticles-loaded FMDV DNA vaccine encoding IL-6 elicited protective immunity against FMDV challenge.

Wang G, Pan L, Zhang Y, Wang Y, Zhang Z, Lü J, Zhou P, Fang Y, Jiang S.

PLoS One. 2011;6(11):e27605. doi: 10.1371/journal.pone.0027605. Epub 2011 Nov 15.

20.

Delivery of siRNA therapeutics: barriers and carriers.

Wang J, Lu Z, Wientjes MG, Au JL.

AAPS J. 2010 Dec;12(4):492-503. doi: 10.1208/s12248-010-9210-4. Epub 2010 Jun 11. Review.

Supplemental Content

Support Center